Related by context. All words. (Click for frequent words.) 71 HIV integrase 68 HIV integrase inhibitor 66 liposomal formulation 66 HCV protease inhibitor 64 investigational integrase inhibitor 64 small molecule glucokinase 63 polymerase inhibitor 63 targeted radiotherapeutic 63 PDE4 inhibitor 63 PORxin TM 63 reslizumab 63 immunotherapeutic vaccine 63 Onalta 62 epothilone 62 developing TB4 62 small molecule Hedgehog 62 LHRH antagonist 62 therapeutic monoclonal antibody 62 Anticalin 62 metaglidasen 62 integrase inhibitor 62 apricitabine ATC 62 anticancer compound 61 IMA# 61 MAXY G# 61 Marqibo TM 61 intranasal formulation 61 Enhanze Technology 61 CCR5 inhibitor 61 recombinant biopharmaceutical 61 humanized monoclonal antibody 61 HCV polymerase inhibitor 61 nucleoside analogue 61 PNP inhibitor 61 Nanobody 61 CCR5 antagonist 61 histone deacetylase HDAC inhibitor 61 orally bioavailable 61 EOquin 61 PHX# 61 ALN PCS 61 Albugon 61 Fleximer 61 synthetic retinoid 61 Aurora kinase inhibitor 61 Pazopanib 61 nucleotide analogue 61 Onconase 60 Allovectin 7 60 HyACT 60 investigational humanized monoclonal antibody 60 Zolinza 60 Panzem R 60 oral prodrug 60 BCR ABL inhibitors 60 fusion inhibitor 60 MEK inhibitors 60 IAP inhibitors 60 inhaled formulation 60 antisense drug 60 Orphan Drug status 60 IMiDs R 60 LentiVector technology 60 signal transduction inhibitor 60 Orphan Drug designation 60 nucleoside analog 60 Nexavar ® 60 HSP# inhibitor 60 Aurexis 60 PRT# 60 oral NKTR 60 selective androgen receptor modulator 60 TLR9 agonist 60 Iluvien ® 60 MEK inhibitor 60 5 HT3 antagonist 60 chemotherapeutic agent 60 glucokinase activator 59 delivers fluocinolone acetonide FA 59 HuMax TAC 59 Nexavar sorafenib 59 histone deacetylase HDAC inhibitors 59 Nanobodies 59 multi kinase inhibitor 59 JAK inhibitor 59 chimeric monoclonal antibody 59 Virulizin 59 oral Factor Xa 59 Onalta ™ 59 HuLuc# 59 ixabepilone 59 Selective Electrochemical Tumor Ablation 59 Syncria 59 paclitaxel Taxol ® 59 oral antiviral 59 Troxatyl 59 stable nucleic acid 59 Debio 59 non nucleoside inhibitor 59 renin inhibitor 59 HGS# 59 highly selective inhibitor 59 Intravenous Human 59 novel histone deacetylase 59 non nucleoside HCV 59 Amrubicin 59 Mipomersen 59 receptor tyrosine kinase inhibitor 59 Argatroban 59 Protexia ® 59 ADP receptor antagonist 59 HCV nucleoside polymerase inhibitors 59 Atripla combines 59 radiation sensitizer 59 Herceptin trastuzumab 59 SNT MC# 59 DPP4 inhibitor 59 Etravirine 59 angiogenesis inhibitor 59 Intravenous CP 59 AKT inhibitor 59 oncolytic virus therapies 59 Modrenal R 59 Fc fusion protein 59 Ceflatonin 59 vascular disrupting agent 59 Onco TCS 59 Pathway Inhibitor 59 Archexin 59 telomerase therapeutic 59 XL# XL# 59 cathepsin K inhibitor 59 DNA RNA Medicines 59 dutogliptin 59 Locked Nucleic Acid LNA 59 Prezista darunavir 59 subcutaneous formulation 59 treat opioid induced 59 targeted antifolate 59 Civacir 59 lapatinib Tykerb 59 Bendamustine 59 Maribavir 59 novel oral anticoagulant 59 acetonide FA 58 vinca alkaloid 58 Maraviroc 58 AtuRNAi 58 ATL# [001] 58 Targeted Chemotherapy 58 paclitaxel Taxol 58 oral proteasome inhibitor 58 regorafenib 58 acyclovir Lauriad R 58 NEBIDO R 58 MKC# MKC# PP 58 oral dihydropyrimidine dehydrogenase DPD 58 YONDELIS 58 proteasome inhibitor 58 systemic RNAi therapeutic 58 Pradefovir 58 virus HCV protease inhibitor 58 vaccine adjuvant 58 novel RNAi therapeutics 58 angiotensin II receptor blocker 58 Clevudine 58 Guanilib 58 antifolate 58 MVA BN R 58 HCV protease inhibitors 58 RGB # 58 mTOR inhibitor 58 Hsp# inhibitor 58 therapeutic peptide 58 Luteinizing Hormone Releasing Hormone 58 investigational compound 58 forodesine 58 Nanobody ® 58 deforolimus 58 Solazed 58 Anticalin R 58 Bezielle 58 PharmFilm ® 58 novel peptide 58 eligen R technology 58 PEGylated interferon 58 Tyrima 58 ALN VSP 58 Kosan dependence 58 anticancer agent 58 HuCAL 58 siRNA therapeutic 58 PDE7 58 Davanat 58 radiotherapeutic 58 BAY #-# 58 tyrosine kinase inhibitor 58 LentiVector 58 erlotinib Tarceva 58 lipid nanoparticle 58 maturation inhibitor 58 mertansine 58 Gleevec imatinib mesylate 58 generation nucleoside analog 58 Factor VIIa 58 Preclinical studies suggest 58 imatinib Gleevec ® 58 methylnaltrexone 58 rxRNA 58 PARP inhibitor 58 rheumatoid arthritis thrombocytopenia 58 Azedra 58 DAVANAT ® 58 vaccine GRNVAC1 58 MT# MEDI 58 Selzentry maraviroc 58 molecular imaging radiopharmaceutical 58 amrubicin 58 GW# [003] 58 volociximab 58 proprietary BiTE ® 58 Pertuzumab 58 mitogen activated ERK kinase 58 dasatinib Sprycel ® 58 Zalbin 58 patented Bioral 58 DAVANAT R 58 Hemopurifier ® 58 HepDirect 58 Revlimid lenalidomide 58 CCR9 antagonist 57 Sustiva efavirenz 57 OncoVEX GM CSF 57 Darunavir 57 ATL# [002] 57 polymerase inhibitors 57 HCV polymerase 57 seliciclib CYC# 57 IMiDs ® compound 57 XmAb ® 57 XmAb 57 developing Bicifadine serotonin 57 proven DuraSite ® 57 Xanafide 57 methylnaltrexone bromide 57 RhuDex ® 57 Teysuno 57 IMiDs ® 57 tiapamil 57 Mepact 57 humanized antibody 57 apaziquone 57 CEQ# 57 panitumumab Vectibix 57 anti CD3 monoclonal 57 PLK1 SNALP 57 ABL inhibitor 57 ospemifene 57 kinase inhibitor 57 epothilones 57 potently inhibit 57 rNAPc2 57 HIV maturation inhibition 57 Dapagliflozin 57 liposomal delivery 57 enhanced skin permeation 57 hepatitis C protease inhibitor 57 entinostat 57 RNAi therapeutic targeting 57 Insegia 57 CCR5 antagonists 57 HepeX B 57 non nucleoside 57 ImmunoGen TAP technology 57 Cloretazine ® 57 SPL# Gel vaginal microbicide 57 Taxotere docetaxel 57 Elvitegravir 57 hepatitis B immune globulin 57 ketolide antibiotic 57 protease inhibitor 57 Blinatumomab 57 thalidomide Thalomid 57 Gleevec imatinib 57 Ridaforolimus 57 investigational oral 57 prostone 57 oral ghrelin agonist 57 HuMax 57 LymphoStat B TM 57 forodesine hydrochloride 57 TRAIL receptor antibodies 57 exon skipping 57 Velcade bortezomib 57 alvespimycin 57 AEG# 57 oral nucleoside analogue 57 Ixempra 57 evaluating tivozanib 57 Firdapse 57 generation purine nucleoside 57 HCV NS5B polymerase 57 antiplatelet agent 57 Roche SWX ROG 57 GPR# agonist 57 oral anticancer 57 Talabostat 57 adrenergic regulation 57 platinum chemotherapeutic 57 elvucitabine 57 allosteric modulator 57 highly selective adenosine 57 Relivar 57 XL# XL# XL# XL# 57 BiTE antibody 57 TBC# 57 atazanavir Reyataz 57 injectable formulation 57 SARMs 57 Pyridorin 57 drug conjugate ADC 57 Kaletra lopinavir ritonavir 57 drug ISA# 57 MOVIPREP R 57 Ceflatonin R 57 proteasome inhibitors 57 small molecule tyrosine 57 Epivir 57 taxane chemotherapy 57 Factor Xa inhibitor 57 Cetrorelix 57 siRNA therapeutics 57 ThermoDox R 57 PF # [002] 57 RNAi therapeutic 57 investigational drug 57 orally dosed 57 SERMs 57 Annamycin 57 CDP# 57 Emselex 57 aerosolized AAT 57 RNA antagonists 57 atacicept 56 DB# [003] 56 BYETTA ® 56 Erlotinib 56 GLPG# 56 humanized monoclonal antibodies 56 AAG geldanamycin analog 56 alkylating agent 56 vemurafenib 56 Tarceva erlotinib 56 TNF Tumor Necrosis Factor 56 erlotinib Tarceva ® 56 MT#/MEDI-# 56 Fodosine 56 XL# anticancer compounds 56 sapropterin dihydrochloride 56 IMiD 56 MorphoSys proprietary 56 Avastin bevacizumab 56 Entocort 56 nucleoside analogs 56 CTLA4 Ig 56 receptor modulators 56 personalized immunotherapy 56 highly selective endothelin 56 Epothilones 56 nucleoside analogues 56 selective immunoproteasome inhibitor 56 long acting muscarinic 56 Aviptadil 56 mda 7 56 gefitinib Iressa 56 sodium glucose transporter 56 targeting CD# 56 motexafin gadolinium Injection 56 TKM ApoB 56 Vidaza azacitidine 56 Zenpep 56 EP #R 56 CORT # 56 kinase inhibitors 56 Vicriviroc 56 candidate ridaforolimus 56 dasatinib Sprycel 56 photoprotective drug 56 P#X# antagonist 56 aurora kinase 56 Orazol 56 oral taxane 56 Fresenius Biotech 56 RANK Ligand inhibitor 56 AQ4N 56 danoprevir 56 PKC# 56 Solasia 56 TOCOSOL 56 MicroDose 56 Orphan Drug designations 56 orally administered inhibitor 56 HIV integrase inhibitors 56 pharmacological chaperone 56 Panzem 56 Cetuximab Erbitux 56 Preotact 56 retaspimycin hydrochloride 56 ZEFTERA TM Zevtera TM 56 Fludara ® 56 histone deacetylase inhibitor 56 Aurora kinase 56 Ophthotech 56 Sutent sunitinib 56 Dasatinib 56 XmAb# 56 Temsirolimus 56 Fortigel 56 adalimumab Humira 56 pertuzumab 56 Alnylam RNAi 56 NTDDS 56 IAP inhibitor 56 ALN TTR 56 immunomodulator 56 Interferon alpha 56 Dynepo 56 protein kinase inhibitor 56 phase IIb clinical 56 ABILIFY ® 56 leading oral taxane 56 small molecule inhibitor 56 gastro intestinal inflammation 56 Agensys subsidiary 56 THR beta agonist 56 TLR8 agonist 56 Filgrastim 56 targeting PCSK9 56 immune modulating 56 Junovan TM 56 Locked Nucleic Acid 56 small molecule PEGylation 56 Icatibant 56 anticancer agents 56 Proellex TM 56 PrevOnco 56 tkRNAi 56 Xyfid TM 56 generation antisense 56 Pancreate 56 isoform selective 56 Isis antisense 56 cancer immunotherapies 56 tenofovir Viread 56 Pimavanserin 56 Simulect 56 oncolytic 56 histone deacetylase HDAC 56 Marqibo 56 Epothilone D 56 CCX# 56 Peginterferon alfa 2b 56 RNAi Therapeutic 56 siRNA delivery 56 betrixaban 56 inflammatory autoimmune diseases 56 NASDAQ CGEN announced 56 AEZS 56 oral isoform selective HDAC 56 Clofarabine 56 Angiocept 56 MKC# 56 HDAC inhibitor 56 Vaccinex 56 novel immunomodulatory 56 Elagolix 56 VersaFilm 56 Traficet EN 56 PSN# [002] 56 PI3K inhibitor 56 Evoltra ® 56 Vidofludimus 56 temsirolimus 56 Bicifadine 56 Silodosin 56 Veronate 56 Lixivaptan 56 intranasal insulin product 56 Nanobody R 55 Rapinyl 55 androgen receptor antagonist 55 immune modulators 55 tamibarotene 55 HuCAL antibodies 55 KNS # 55 ATG Fresenius S 55 PI3K/Akt pathway inhibitor 55 YONDELIS R 55 delta opioid receptor 55 elotuzumab 55 LY# [003] 55 FOLOTYN ® 55 personalized cellular immunotherapy 55 Panzem R NCD 55 Laquinimod 55 investigational oral inhibitor 55 celgosivir 55 darunavir 55 Cx# [002] 55 fesoterodine 55 Cyclosert TM 55 Arcalyst 55 Aflibercept 55 candidate deforolimus 55 peripherally acting 55 pan HDAC inhibitor 55 SMaRT ™ 55 topical anti infective 55 PGL# 55 IMC #F# 55 PEG SN# 55 oral formulation 55 HuMax CD4 55 GED aPC 55 TLR9 agonists 55 Perifosine 55 Zorbtive TM 55 Stapled Peptide 55 Lupuzor 55 Scancell 55 Desmoteplase 55 Sym# 55 EndoTAG TM 55 TH# [003] 55 Enanta 55 TOCOSOL Paclitaxel 55 reverse transcriptase inhibitor 55 DPX Survivac 55 ALTROPANE R 55 oral PTH 55 Pafuramidine 55 Micromet BiTE 55 ProLindac TM 55 ErbB3 HER3 55 romazarit 55 oxazolidinone 55 developing Zerenex ferric 55 Kivexa 55 GSK '# 55 Nebido 55 humanized anti 55 PSN# [001] 55 DepoBupivacaine TM 55 Imatinib mesylate 55 JAK2 inhibitor 55 staphylococcal vaccines 55 Fleximer R 55 Raptiva ® 55 LymphoStat B belimumab 55 HepDirect R 55 Bavarian Nordic patented 55 HIV Integrase Inhibitor 55 farletuzumab 55 selective androgen receptor modulators 55 ZFP Therapeutics 55 Tarceva TM 55 Micromet proprietary BiTE 55 Rasagiline 55 DiLA2 55 immunomodulatory therapy 55 naproxen esomeprazole magnesium 55 Unit Dose Budesonide 55 R#/MEM 55 BiTE 55 protein tyrosine phosphatase 1B 55 Rituxan rituximab 55 IRX 2 55 vidofludimus 55 anti CD3 55 Galenea 55 renin inhibitors 55 selective estrogen receptor modulator 55 commercialize deforolimus 55 Tarvacin 55 inhibit replication 55 HCV polymerase inhibitors 55 vosaroxin 55 refractory chronic lymphocytic 55 Neo Kidney Augment ™ 55 novel peptides 55 MKC# MT 55 conventional monoclonal antibodies 55 Cimzia certolizumab pegol 55 Exenatide LAR 55 AP# [003] 55 JAK3 inhibitor 55 CINTREDEKIN BESUDOTOX 55 AERx iDMS 55 NXL# 55 Retacrit 55 LNP formulations 55 outlicensed 55 drug conjugate 55 Quark Biotech 55 Alfacell proprietary ribonuclease 55 lumiliximab 55 Vandetanib 55 Curaxin CBLC# 55 GV# [001] 55 Tibotec Therapeutics division 55 histamine dihydrochloride 55 product candidate Lpathomab 55 pradefovir 55 Loramyc 55 topically applied SEPA 55 Lodotra 55 SGLT Inhibitors 55 Cobalamin 55 molecular chaperone regulation 55 Raltegravir 55 mSEPT9 biomarker 55 NeoLipid R 55 aleglitazar 55 Bafetinib 55 HCV protease 55 small molecule inhibitors 55 liposomal 55 DiLA 2 55 Votrient 55 Ostabolin C TM 55 IgG1 monoclonal antibody 55 Aptivus 55 InterfeRx 55 Hepatitis C Virus HCV 55 Epigenomics proprietary 55 New Chemical Entities 55 tipranavir 55 selective kinase inhibitor 55 SYCREST 55 Proquin XR 55 Spiegelmer 55 tanespimycin 55 dirucotide MBP# 55 clofarabine 55 BENLYSTA TM 55 investigational pharmacologically unique 55 systemic RNAi 55 histone deacetylase inhibitors 55 2 inhibitor CYT# 55 candidate Zenvia 55 compound ISA# 55 Dicer Substrate Technology 55 TELINTRA 55 Daclizumab 55 immunotherapeutic 55 ViiV Healthcare 55 orally administered 55 HepaGam B 55 Leukine ® 55 PARP inhibitors 55 nucleotide analog 55 HepDirect prodrug 55 Nektar PEGylation technology 55 Vilazodone 55 human IgG1 monoclonal 55 investigational atypical antipsychotic 55 sodium glucose cotransporter 55 accumulate preferentially 55 Bioral 55 CBLC# 55 inhaled antibiotic 55 Humira adalimumab 55 Sumavel DosePro 55 AVN# [001] 55 RELISTOR ® 55 ASONEP 55 POSIDUR TM ELADUR TM 55 Liprotamase 55 nitric oxide donating 55 OGeS 55 TYZEKA 55 PEG Interferon lambda 55 BCG refractory 55 chemically modified siRNA 55 Mirapexin 55 diabetes irritable bowel 55 Yervoy 55 dacetuzumab 55 Taiho Pharmaceutical 55 JAK1 55 MAGE A3 ASCI 55 PREOS R 55 Novosom 55 Curaxin 55 ocular formulation 55 human monoclonal antibody 55 ATL/TV# 55 hepatitis C HCV 55 Atrasentan 54 Avian Transgenic Technology 54 Surfaxin LS 54 Intraject 54 PEGylated Fab fragment 54 ALN TTR# 54 R#/MEM # 54 ONCONASE R 54 JOULFERON 54 Cerashield 54 Intelence 54 Kuvan R 54 Aplidin 54 ASG 5ME 54 Myocet 54 selective receptor agonist 54 antisense inhibitor 54 Nimotuzumab 54 Adnectin 54 Telzir 54 Vicinium TM 54 delivery polymer matrix 54 DOS# 54 RELOVAIR ™ 54 Lenalidomide 54 candidate ATHX 54 nasal calcitonin product 54 Eligen ® Technology 54 UVIDEM 54 Carfilzomib 54 IMPDH inhibitor 54 fostamatinib 54 Cloretazine 54 valtorcitabine 54 insulin sensitizing 54 VivaGel TM 54 preclinical compounds 54 Theratope 54 VISICOL R 54 TRO# 54 Voreloxin 54 antibody fragment therapeutics 54 Epratuzumab 54 therapeutic monoclonal antibodies 54 intranasal formulations 54 ulimorelin 54 CVac 54 Zelrix 54 fusion inhibitors 54 small molecule thrombopoietin 54 treat male hypogonadism 54 orally disintegrating 54 delta isoform 54 LNPs 54 pancreatic enzyme replacement 54 thymalfasin 54 Allovectin 7 ® 54 gastrointestinal stromal tumors 54 ularitide 54 HCD# [002] 54 tafamidis 54 TREANDA 54 vivo electroporation 54 sorafenib tablets 54 AdVac 54 Combivir Kivexa 54 MEK Inhibitor 54 Bruton tyrosine kinase Btk 54 Vegenics 54 TG# [003] 54 CYT# potent vascular disrupting 54 5 HT6 54 selective agonist 54 Amplimexon 54 TRACON Pharmaceuticals 54 Inotek Pharmaceuticals Corporation 54 GLP toxicology studies 54 CD# antibody [001] 54 Uplyso 54 oral talactoferrin 54 ZK EPO 54 #D#C# 54 lixivaptan 54 CobaCyte 54 selective antagonist 54 davalintide 54 Tumour Vascular Disrupting Agent 54 antisense drugs 54 Tarmogen 54 Solzira ™ 54 BEMA TM Fentanyl 54 Sphingomab 54 Abacavir 54 immune modulator 54 prodrug 54 AtuPLEX 54 SGLT2 inhibitor 54 OHR/AVR# 54 Alvesco R 54 antimitotic 54 omecamtiv mecarbil formerly 54 filgrastim 54 Exherin 54 INT# [002] 54 Femring ® 54 MorphoSys antibody 54 BEXXAR 54 Kosan motilin agonist 54 Hsp# inhibitors 54 DU #b 54 ErbB3 54 IND submission 54 THALOMID 54 NEUGENE R 54 poly ADP ribose polymerase 54 interferon lambda 54 potent inhibitor 54 selective inhibitor 54 pitavastatin 54 BUPHENYL R 54 Degarelix 54 Opterone R 54 visilizumab 54 HuCAL PLATINUM 54 XOMA 3AB 54 L BLP# 54 Merck Serono division 54 Virulizin R 54 OMAPRO ™ 54 Vorinostat 54 candidate epratuzumab 54 immune modulation 54 Stimuvax R 54 Firazyr 54 erlotinib Tarceva R 54 XIAFLEX ™ 54 molecular entities NMEs 54 PORxin TM platforms 54 successfully commercialize Iluvien 54 RAPAFLO 54 ProSavin 54 Ceplene TM 54 gemcitabine Gemzar 54 tranilast 54 insulin sensitizer 54 adenosine A2A 54 maturation inhibition 54 Kevetrin ™ 54 ELND-#/AZD-# 54 Vertex telaprevir 54 XP# XP# 54 TRX1 54 ghrelin antagonist 54 Tofacitinib 54 anti angiogenic agent 54 Ciclesonide 54 elvitegravir 54 Nasulin TM 54 SinuNase ™ 54 Prednisporin 54 NuMimetic TM 54 bortezomib Velcade 54 Juvantia 54 EndoTAG TM -1 54 Inc. AMEX YMI 54 herpetic keratitis 54 Tesetaxel 54 anticancer therapeutics 54 immunotherapeutics 54 ocrelizumab 54 BMS # 54 sorafenib Nexavar 54 IMiDs 54 DFMO 54 novel VDA molecule 54 Nasdaq OMER 54 Aganocide ® 54 reversible inhibitor 54 Aloxi R 54 Hycamtin 54 DsiRNA 54 BioWa 54 5 lipoxygenase inhibitor 54 immunological diseases 54 next generation URAT1 54 RONDEL ™ 54 Pruvel TM 54 Zemiva TM 54 biobetter 54 glucagon receptor 54 Treanda 54 evaluating satraplatin 54 ALN HTT 54 Abiraterone acetate 54 NexACT R 54 Wellstat 54 goserelin 54 novel therapeutic antibodies 54 novel topoisomerase 54 ENMD # 54 ridaforolimus 53 Prodarsan ® 53 Affibody 53 factor G CSF 53 topical gel formulation 53 DexaSite 53 Zybrestat 53 ARRY # 53 Anticalins R 53 ALN RSV program 53 triphendiol 53 predictive biomarkers 53 Valacyclovir 53 dipeptidyl peptidase 4 53 nucleoside 53 Locteron exclusively 53 chemical entities NCEs 53 unpartnered 53 oral ridaforolimus 53 chemopreventive agent 53 PEGylation technology 53 cleavable linker 53 OncoVEX 53 Captisol 53 TKB# 53 relapsed leukemia 53 immunosuppressant 53 Aerosurf 53 DP VPA 53 Tesmilifene 53 tubulin inhibitor 53 R sorafenib tablets 53 AEGR 53 oncology therapeutics 53 Atazanavir 53 Prestige Antibodies 53 Nanobodies R 53 Ecallantide 53 Kinase Inhibitor 53 Inotek 53 Sylvie Gregoire President 53 oncology indications 53 EndoTAG 53 Tostrex 53 anticancer therapies 53 MGCD# [001] 53 Shigamabs ® 53 PNT# 53 huC# DM4 53 investigational 53 intravesical infusion therapy 53 partial agonist 53 Rotarix ® 53 ASONEP TM 53 small molecule 53 antisense oligonucleotide 53 Cerimon 53 NYSE PFE Exelon Rivastigmine 53 etanercept Enbrel 53 Losartan 53 intranasal delivery 53 Zenapax 53 AFFiRiS 53 Personalized Immunotherapy 53 vinflunine 53 systemically administered 53 Presents Preclinical Data 53 preclinical 53 orphan drug 53 Transdel TM 53 preclinical efficacy 53 Triapine 53 Aegera 53 investigational antiplatelet agent 53 GTC recombinant human 53 markets HP Acthar 53 Perforomist TM formoterol fumarate 53 humanized antibodies 53 Mersana 53 Olaparib 53 GLP1 INT TM 53 Campath alemtuzumab 53 MORAb 53 RECOTHROM R 53 Hsp# Inhibitor 53 ArQule Kinase Inhibitor Platform 53 CYC# 53 Somatuline Depot 53 DepoDur 53 include Altastaph TM 53 Nasdaq PGNX today 53 MAXY VII 53 MOR# 53 VaxImmune 53 subcutaneously administered 53 castrate resistant prostate cancer 53 VitiGam 53 KuDOS 53 Omacetaxine 53 aldehyde dehydrogenase ALDH2 deficiency 53 CYT# vascular disrupting